Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intra-operative Pancreatoscopy in Patients With IPMN

NCT: NCT03729453 · ACTIVE_NOT_RECRUITING

NCT IDNCT03729453
StatusACTIVE_NOT_RECRUITING
Start Date2019-03-20
Completion2027-05

Brief Summary

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

Frequently Asked Questions

What is Intra-operative Pancreatoscopy in Patients With IPMN?

Intra-operative Pancreatoscopy in Patients With IPMN is a clinical trial registered under NCT03729453. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03729453?

The current status of NCT03729453 (Intra-operative Pancreatoscopy in Patients With IPMN) is: ACTIVE_NOT_RECRUITING.

When did Intra-operative Pancreatoscopy in Patients With IPMN start?

Intra-operative Pancreatoscopy in Patients With IPMN started on 2019-03-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.